多学科团队差异对肺癌结果比较分析和治疗平等的影响
Torben Riis Rasmussen1,2, Anja Gouliaev3, Erik Jakobsen4
1Department of Respiratory Diseases and Allergy, Aarhus University Hospital (AUH), Aarhus N, DK-8200, Denmark. torbrasm@rm.dk.
BMC cancer
|November 18, 2024
概括
在丹麦的多学科团队 (MDTs) 中,肺癌病期一致性各不相同. 虽然整体阶段和治愈能力的协议是中等的,但第三阶段肺癌的治疗意图显示出不良一致性,突出了需要改进MDT决策的需要.
科学领域:
- 在瘤学瘤学.
- 临床研究 临床研究
- 医疗保健服务研究 医疗服务研究
背景情况:
- 多学科团队 (MDT) 会议对于肺癌管理至关重要.
- 评估MDT评估的一致性对于可比的患者结果至关重要.
- 关于MDT决策一致性的现实数据有限.
研究的目的:
- 评估整个丹麦MDT站点肺癌分期和治疗意图的一致性.
- 在国家范围内评估肺癌病例评估的可比性.
- 确定MDT决策中的质量改进领域.
主要方法:
- 60个虚构的肺癌病例图片与图像被分发到四个丹麦MDT网站.
- 病例被MDT评估,就好像他们是真正的病人一样.
- 使用卡帕统计数据分析了TNM分期和治疗意图一致性.
主要成果:
- 对于指定的肺癌阶段 (Kappa=0.62) 和治愈性评估 (Kappa=0.72) 发现了适度一致.
- 在第三阶段肺癌病例中,观察到治疗意图的一致性较差 (Kappa=0.32).
- 在MDT决策过程中,特别是在复杂案件中,发现了显著的变化.
结论:
- 在丹麦MDT的肺癌阶段评估一致性是不理想的.
- 由于MDT决策不一致,中心之间对治疗结果的比较分析可能会有偏见.
- 需要有针对性的质量改进举措,以提高MDT建议的一致性,特别是第三阶段肺癌.
更多相关视频
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
221
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.4K
相关概念视频
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Comparing the Survival Analysis of Two or More Groups
154
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
154
